指南2016.pdf

Clinical Practice Guidelines in Oncology ( Guidelines®)
Bladder Cancer
Asia Consensus Statements Version 1
[2016]
−Based upon Guidelines Bladder Cancer Version −

®
Clinical Practice Guidelines in Oncology ( Guidelines®) ‒ Asia Consensus Statements: Bladder Cancer
Panel Members Bannakij Lojanapiwat, MD Special Thanks to:
Chiang Mai University, Chiang Mai, Thailand
Chair of the Guidelines Panel for
Mikio Namiki, MD, PhD
Hideyuki Akaza, MD, PhD [Co-Chair] Bladder Cancer:
Kanazawa University, Kanazawa, Japan
University of Tokyo, Tokyo, Japan Peter E. Clark, MD [Chair]
Rainy Umbas, MD, PhD [Co-Chair] Hiroyuki Nishiyama, MD, PhD Vanderbilt-Ingram Cancer Center, Tennessee,
University of Indonesia, Jakarta, Indonesia University of Tsukuba, Tsukuba, Japan United States
Yen-Chuan Ou, MD, PhD
Jason Chia-Hsien Cheng, MD, PhD Taichung Veterans General Hospital, Taichung,
National Taiwan University Hospital, Taipei, Taiwan Taiwan Acknowledgement
Byung Ha Chung, MD, PhD Seiichiro Ozono, MD, PhD Medical writing services provided by
Yonsei University College of Medicine, Seoul, Hamamatsu University School of Medicine, Reno Medical . (M3 group)
South Korea Hamamatsu, Japan
Narmada Gupta, MBBS, MS, ., FAMS, Dennis Serrano, MD, MHA
University of the Philippines College of Medicine, Conflict of Interest (COI)
Medanta Institute of Kidney & Urology, Haryana, Manila, the Philippines
India Hong Gee Sim, MBBS, MRCSEd, MMED, All panel members have disclosed COI
FAMS associated with the Asia Consensus
Shiro Hinotsu, MD, PhD Statements of Guidelines ( ACS).
Gleneagles Medical Centre, Singapore
Okayama University, Okayama, Japan For more information, please contact the
Shigeo Horie, MD, PhD Jae Mann Song, MD, PhD ACS secretariat.
Juntendo University, Tokyo, Japan Wonju College of Medicine Yonsei University, Wonju, Reno Medical .
South Korea
Choung Soo Kim, MD, PhD E-mail: nacs-******@